找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders; Shabir Ahmad Ganai Book 2019 Springer Nature Singapore Pte Ltd. 2019

[復(fù)制鏈接]
樓主: Radiofrequency
11#
發(fā)表于 2025-3-23 13:43:03 | 只看該作者
Current Challenges with HDAC Inhibitor-Based Therapeutic Intervention Against Neurological Maladiesand high structural identity at the active sites of different HDACs. Importantly, the lack of blood-brain barrier permeability of HDACi restricting the use of these marvellous inhibitors against neurological disorders is detailed.
12#
發(fā)表于 2025-3-23 14:58:07 | 只看該作者
rders.It uniquely highlights the potential of various HDAC i.This book provides an outline of epigenetics as a whole, while also specifically examining a range of epigenetic players, including histone acetyl transferases (HATs) and histone deacetylases (HDACs). It chiefly focuses on the emerging tar
13#
發(fā)表于 2025-3-23 21:15:14 | 只看該作者
14#
發(fā)表于 2025-3-24 01:48:14 | 只看該作者
Different Groups of HDAC Inhibitors Based on Various Classifications,n and source. Further, the detailed account of various approved HDACi for treating various malignancies will be given. Notably, I will discuss the different structural components of a typical HDAC inhibitor.
15#
發(fā)表于 2025-3-24 03:46:20 | 只看該作者
HDAC Inhibitors as Novel Therapeutic Option Against Therapeutically Challenging Neurological Disordfect of various HDACi against neurological disorders including Alzheimer’s disease, Parkinson’s disease, and epilepsy. The underlying molecular players modulated by these inhibitors in bringing therapeutic effect will also be taken into consideration.
16#
發(fā)表于 2025-3-24 08:50:50 | 只看該作者
17#
發(fā)表于 2025-3-24 12:56:45 | 只看該作者
18#
發(fā)表于 2025-3-24 16:54:59 | 只看該作者
Epigenetics and its Implications in Neurological Disorders,one proteins undergo. Moreover, the altered activity and expression of various epigenetic enzymes in distinct neurological disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS) will be thoroughly discussed.
19#
發(fā)表于 2025-3-24 23:00:02 | 只看該作者
Designing of Selective and Brain-Penetrant HDAC Inhibitors for Effective Therapy Against Neurologiccomputational and medicinal chemistry approaches for designing selective HDAC inhibitors. Further, the chapter also gives bird’s eye view on image-guided approach for identifying the brain-penetrant HDACi.
20#
發(fā)表于 2025-3-25 02:40:23 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
广灵县| 来凤县| 五大连池市| 乐安县| 乐都县| 大冶市| 应用必备| 嘉峪关市| 垫江县| 独山县| 北川| 邻水| 出国| 闸北区| 永兴县| 曲阳县| 奉新县| 曲水县| 枣强县| 诸暨市| 茶陵县| 西宁市| 青海省| 诸暨市| 广德县| 峡江县| 溆浦县| 信阳市| 金沙县| 拜城县| 清苑县| 武川县| 长宁区| 沙河市| 北宁市| 高阳县| 永靖县| 巍山| 云阳县| 休宁县| 宁安市|